Nanhui Xu

A vascular disrupting agent overcomes tumor multidrug resistance by skewing macrophage polarity toward the M1 phenotype.

W. Ye, Min-feng Chen, Dongmei Zhang, 2018, Cancer letters.

Targeting NUFIP1 Suppresses Growth and Induces Senescence of Colorectal Cancer Cells

Li Li, Lihui Wei, Aling Shen, 2020, Frontiers in Oncology.

Identification of Cysteine Protease Inhibitor CST2 as a Potential Biomarker for Colorectal Cancer

Lihui Wei, Aling Shen, Jun Peng, 2021, Journal of Cancer.

Abstract 1812:In vitroandin vivoantiangiogenic activity of desacetylvinblastine monohydrazide through inhibition of VEGFR2 and Axl pathways

W. Ye, Min-feng Chen, Dong-Mei Zhang, 2017 .

In vitro and in vivo antiangiogenic activity of desacetylvinblastine monohydrazide through inhibition of VEGFR2 and Axl pathways.

W. Ye, Min-feng Chen, Dongmei Zhang, 2016, American journal of cancer research.

Pericyte-targeting prodrug overcomes tumor resistance to vascular disrupting agents.

Qiang Yu, C. Shi, W. Ye, 2017, The Journal of clinical investigation.

In vitro and in vivo antiangiogenic activity of desacetylvinblastine monohydrazide through inhibition of VEGFR2 and Axl pathways.

W. Ye, Dongmei Zhang, Kaihe Ye, 2016, American journal of cancer research.